openPR Logo
Press release

Metachromatic Leukodystrophy Pharmaceutical and Healthcare Analysis Information

12-18-2017 07:55 AM CET | Health & Medicine

Press release from: WISE GUY RESEARCH CONSULTANTS PVT LTD

/ PR Agency: WISE GUY RESEARCH CONSULTANTS PVT LTD
Metachromatic Leukodystrophy

Metachromatic Leukodystrophy

Pune, India, 18th December 2017: WiseGuyReports announced addition of new report, titled “Metachromatic Leukodystrophy (MLD) - Pipeline Review, H2 2017”.

Summary
Metachromatic leukodystrophy is an inherited disorder characterized by the accumulation of fats called sulfatides in cells. Symptoms include vision problems leading to blindness, personality changes, and motor disturbances such as clumsiness, muscle weakness (hypotonia), rigidity, inability to coordinate movement (ataxia), and/or muscle spasms especially of the neck, spine, arms, and legs. Treatment for metachromatic leukodystrophy is symptomatic and supportive.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2627298-metachromatic-leukodystrophy-mld-pipeline-review-h2-2017

Companies mentioned
ArmaGen Inc

GlaxoSmithKline Plc

Recursion Pharmaceuticals Inc

RegenxBio Inc

Shire Plc

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Metachromatic Leukodystrophy (MLD) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Metachromatic Leukodystrophy (MLD) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Metachromatic Leukodystrophy (MLD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Metachromatic Leukodystrophy (MLD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Preclinical stages are 1, 2 and 2 respectively. Similarly, the Universities portfolio in Phase II and Phase I stages comprises 1 and 1 molecules, respectively.

Metachromatic Leukodystrophy (MLD) (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Metachromatic Leukodystrophy (MLD) (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Metachromatic Leukodystrophy (MLD) (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Metachromatic Leukodystrophy (MLD) (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Metachromatic Leukodystrophy (MLD) (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Metachromatic Leukodystrophy (MLD) (Central Nervous System)

Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Metachromatic Leukodystrophy (MLD) (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Metachromatic Leukodystrophy (MLD) (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Metachromatic Leukodystrophy (MLD) - Overview 5
Metachromatic Leukodystrophy (MLD) - Therapeutics Development 6
Pipeline Overview 6
Pipeline by Companies 7
Pipeline by Universities/Institutes 8
Products under Development by Companies 9
Products under Development by Universities/Institutes 10
Metachromatic Leukodystrophy (MLD) - Therapeutics Assessment 11
Assessment by Target 11
Assessment by Mechanism of Action 12
Assessment by Route of Administration 14
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2627298-metachromatic-leukodystrophy-mld-pipeline-review-h2-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metachromatic Leukodystrophy Pharmaceutical and Healthcare Analysis Information here

News-ID: 864418 • Views:

More Releases from WISE GUY RESEARCH CONSULTANTS PVT LTD

Global LIMS Industry Analysis 2020 Market Growth, Trends, Opportunities And Forecast To 2026
Global LIMS Industry Analysis 2020 Market Growth, Trends, Opportunities And Fore …
LIMS Market 2020-2026 New Study Reports “LIMS Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global LIMS Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, LIMS Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global LIMS Market Is Extensively Assessed In The
Asthma Drugs Market 2020 Global Industry Sales, Supply, Demand, Consumption, Analysis And Forecasts To 2026
Asthma Drugs Market 2020 Global Industry Sales, Supply, Demand, Consumption, Ana …
Asthma Drugs Market 2020-2026 New Study Reports “Asthma Drugs Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global Asthma Drugs Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Asthma Drugs Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global Asthma Drugs Market Is Extensively Assessed In The Research
Virtual Reality in Education 2020 Global Market Key Players - Alchemy VR, Avantis Education, EON Reality, Google, Oculus VR, Virtalis - Analysis And Forecast To 2026
Virtual Reality in Education 2020 Global Market Key Players - Alchemy VR, Avanti …
Virtual Reality in Education Market 2020-2026 New Study Reports “Virtual Reality in Education Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global Virtual Reality in Education Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Virtual Reality in Education Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global
Online Jewelry 2020 Global Market Key Players - Cartier, Tiffany & Co, Pandora, Chaumet, Tanishq, Van cleef & arpels-Analysis And Forecast To 2026
Online Jewelry 2020 Global Market Key Players - Cartier, Tiffany & Co, Pandora, …
Online Jewelry Market 2020-2026 New Study Reports “Online Jewelry Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global Online Jewelry Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Online Jewelry Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global Online Jewelry Market Is Extensively Assessed In The Research

All 5 Releases


More Releases for Metachromatic

Global Interbody Cages Market to Progress at a Substantial CAGR by 2026, Asserts …
DelveInsight's 'Interbody Cages Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Interbody Cages and the historical and forecasted Interbody Cages market trends, globally, which comprises of North America, Europe, APAC, and RoW. Some of the Interbody Cages Companies are • Aurora Spine, Inc. • B. Braun Melsungen AG • Benvenue Medical, Inc. • Ulrich Medicals USA • Prodorth • Orthofix International N.V. • Medtronic, plc • Zimmer Biomet, Inc. • NuVasive, Inc. • Johnson &
Angioedema Market, Epidemiology, Treatment, Pipeline, Drugs, Companies and Compe …
Angioedema is swelling underneath the skin. It's usually a reaction to a trigger, such as a medicine or something you're allergic to. It is not normally serious, but it can be a recurring problem for some people and can very occasionally be life-threatening if it affects breathing. DelveInsight's "Angioedema Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Angioedema, historical and forecasted epidemiology as well as the
Gene Therapy Therapeutics-Pipeline Analysis 2018, Clinical Trials & Results | No …
Gene therapy is a technique that involves treatment or prevention of a disease by using genes. Several methodologies are being used in the gene therapy that involve replacing the mutated gene, inactivating or silencing the mutated gene, and introducing a new gene into the body. Download the sample report at: https://www.pharmaproff.com/request-sample/1184 This results in the formation of beneficial protein. A gene cannot be directly delivered into the human body, because of
GervanoRA Announced the Release of Opportunity Assessment Report Titled “Metac …
GervanoRA Data Services (GDS), a premier provider of market research analysis and services based in Goa, India has announced the release of their latest report on Metachromatic Leukodystrophy Pipeline Drugs – Opportunity Assessments, Epidemiology Forecast, Market Dynamics, and Pipeline Analysis H2 2018. GervanoRA’s pipeline analysis and opportunity assessment report “Metachromatic Leukodystrophy: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis, H2 2018” analyzed and assessed Metachromatic Leukodystrophy pipeline molecules for the
Metabolic Disorders Therapeutics Market to Perceive Substantial Growth During 20 …
Metabolic disorders usually occur due to disruption of the normal processes of the body. These disorders can be hereditary or acquired and the symptoms differ from person to person. Some metabolic disorders cause mild symptoms that can be managed with slight medication and lifestyle changes, whereas few can cause life-threatening symptoms, such as breathing problems, seizure, and organ failure. The treatment for inherited metabolic disorders requires long-term nutritional supplementation and
Metachromatic Leukodystrophy Pipeline Therapeutics Review 2018
Metachromatic leukodystrophy (MLD) is an inherited disease that causes fat accumulation in cells. The disease affects the nervous system which produces myelin sheath for insulation and protection of nerves. The fatty deposition, called sulfatides in nerve cells causes the destruction of white matter, which is formed by myelin sheath. It further deteriorates the cognitive functioning of nerves such as an ability to walk, loss of sensation (also known as peripheral